| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/31/2008 | WO2008091540A2 23-substituted bile acids as tgr5 modulators and methods of use thereof |
| 07/31/2008 | WO2008091532A1 Salts of 3-o-(3',3'-dimethylsuccinyl)betulinic acid and solid state forms thereof |
| 07/31/2008 | WO2008091525A2 Anthelmintic macrolactams from nonmuraea turkmeniaca ma 7364 |
| 07/31/2008 | WO2008091375A2 Attenuated salmonella as a delivery system for sirna-based tumor therapy |
| 07/31/2008 | WO2008091349A1 Bifunctional histone deacetylase inhibitors |
| 07/31/2008 | WO2008091338A1 Methods and compositions for the treatment of insulin resistance, diabetes, and diabetes-associated dyslipidemia |
| 07/31/2008 | WO2008091337A1 Polymer-linked-bisphosphonate inhalant formulations and methods for using the same |
| 07/31/2008 | WO2008091252A1 Prevention and treatment of androgen-deprivation induced skeletal-related event (sre) |
| 07/31/2008 | WO2008091246A1 Self-assembling amphiphilic polymers as antiviral agents |
| 07/31/2008 | WO2008091195A1 Novel heteroaryl substituted imidazo [1,2 -a] pyridine derivatives |
| 07/31/2008 | WO2008091170A1 A preparation containing sodium butyrate and the application of a preparation containing sodium butyrate |
| 07/31/2008 | WO2008091167A1 Topical formulation |
| 07/31/2008 | WO2008091161A1 Cosmetic composition containing spermine and emu oil |
| 07/31/2008 | WO2008091021A1 Heterocyclidene-n-(aryl)acetamide derivative |
| 07/31/2008 | WO2008090962A1 Composition for external application to skin |
| 07/31/2008 | WO2008090944A1 Spiro-ring compound |
| 07/31/2008 | WO2008090940A1 Pharmaceutical agent comprising dopamine d2-like receptor agonist as active ingredient and screening method |
| 07/31/2008 | WO2008090884A1 Novel trifluoromethylphenyltetrahydrocinnoline derivative and pharmaceutical use thereof |
| 07/31/2008 | WO2008090857A1 COMPOUND, α1 ADRENALINE RECEPTOR ANTAGONIST, AND COMPOSITION |
| 07/31/2008 | WO2008090850A1 Agent for enhancing the effect of anticancer agent |
| 07/31/2008 | WO2008090749A1 Agent for modification of sh group |
| 07/31/2008 | WO2008090736A1 Pharmaceutical product for prevention and treatment of alzheimer's dementia |
| 07/31/2008 | WO2008090732A1 Pharmaceutical composition |
| 07/31/2008 | WO2008090717A1 Adam inhibitor |
| 07/31/2008 | WO2008090716A1 Anti-wrinkle agent and adam inhibitor |
| 07/31/2008 | WO2008090632A1 Marker for detecting the proposed efficacy of treatment |
| 07/31/2008 | WO2008090631A1 Fucoidan-derived oligosaccharide |
| 07/31/2008 | WO2008090583A1 Phosphated derivatives of polysaccharides and uses thereof |
| 07/31/2008 | WO2008090570A1 Novel antimicrobials |
| 07/31/2008 | WO2008090565A1 Novel thermodynamically stable polymorphic form-l of letrozole |
| 07/31/2008 | WO2008090534A1 Methods and compositions for inhibition of excessive weight gain, reduction of inappropriate eating behaviours and inhibition of binge eating for the treatment of obesity |
| 07/31/2008 | WO2008090526A1 Organometallic compounds |
| 07/31/2008 | WO2008090517A2 Enriched plant extract, compound, and methods for the treatment of proliferative disorders |
| 07/31/2008 | WO2008090440A1 Lipid-based gynaecologic suppository |
| 07/31/2008 | WO2008090434A1 Substituted n-bicyclicalkyl bicyclic carboxyamide compounds |
| 07/31/2008 | WO2008090429A1 Tosylate salt of a therapeutic compound and pharmaceutical compositions thereof |
| 07/31/2008 | WO2008090425A1 Sulfoglycolipid antigens, their process of preparation, and their use against tuberculosis |
| 07/31/2008 | WO2008090382A1 Thiazole and oxazole derivatives for use in the treatment of prion diseases, cancer and conditions of the central nervous system as well as in the regulation of stem cells |
| 07/31/2008 | WO2008090379A1 Pyrazoloquinazolinones as inhibitors of poly(adp-ribose)polymerase (parp) |
| 07/31/2008 | WO2008090366A1 Treatment for respiratory disease |
| 07/31/2008 | WO2008090357A2 N, n; -substituted piperazines binding to melanocortin receptor |
| 07/31/2008 | WO2008090356A1 Thiazolidinone derivatives useful in the treatment of cancer and disorders caused by excess adiposity |
| 07/31/2008 | WO2008090353A1 3 - cinnolinecarboxamide derivatives and their use for treating cancer |
| 07/31/2008 | WO2008090334A1 Serotonin receptor antagonists for treating arthritis |
| 07/31/2008 | WO2008090331A1 Serotonin reuptake inhibitors for treating arthritis |
| 07/31/2008 | WO2008090327A1 New combination for use in the treatment of cancer |
| 07/31/2008 | WO2008090210A1 Methods for preventing and treating neurodegenerative disorders |
| 07/31/2008 | WO2008090209A2 Use of glucopyranosyloxy- pyrazoles for preventing and treating neurodegenerative disorders |
| 07/31/2008 | WO2008090201A1 Use of folic acid, vitamin b6, and vitamin b12 |
| 07/31/2008 | WO2008090200A2 2- piperazin-1-yl-3h-imidazo[4,5-b]pyridine derivatives |
| 07/31/2008 | WO2008090198A1 Use of mtp inhibitors for increasing levels of satiety hormones |
| 07/31/2008 | WO2008090181A1 Purine derivatives |
| 07/31/2008 | WO2008090151A1 Antiviral compounds |
| 07/31/2008 | WO2008090140A1 Aryloxypropanolamines, methods of preparation thereof and use of aryloxypropanolamines as medicaments |
| 07/31/2008 | WO2008090117A1 Pharmaceutical compositions comprising 3, 5-diamin0-6- (2, 3-dichl0phenyl) -l, 2, 4-triazine or r (-) -2, 4-diamino-5- (2, 3-dichlorophenyl) -6-fluoromethyl pyrimidine and an nk1 |
| 07/31/2008 | WO2008090116A1 Novel pharmaceutical compositions |
| 07/31/2008 | WO2008090115A1 Pharmaceutical compositions comprising nk1 receptor antagonists and sodium channel blockers |
| 07/31/2008 | WO2008090114A1 Pharmaceutical compositions comprising 2-methoxy-5- (5-trifluoromethyl-tetrazol-i-yl-benzyl) - (2s-phenyl-piperidin-3s-yl-) |
| 07/31/2008 | WO2008090081A1 Metal salophen complexes for prevention and treatment of cancer |
| 07/31/2008 | WO2008090076A1 Oral pharmaceutical compositions in the form of stabilised aqueous solutions |
| 07/31/2008 | WO2008090073A1 New unsaturated fatty amino-acid derivatives and use thereof in dermal cosmetology |
| 07/31/2008 | WO2008090038A1 Pulverulent pharmaceutical composition comprising ibuprofen and a polyalcohol |
| 07/31/2008 | WO2008089984A2 Process for the preparation of ezetimibe and derivatives thereof |
| 07/31/2008 | WO2008089961A1 Use of phosphatase inhibitors for the treatment of neurodegenerative diseases |
| 07/31/2008 | WO2008089933A2 Benzoquinazole derivatives |
| 07/31/2008 | WO2008089916A1 Pharmaceutical for the treatment of sepsis |
| 07/31/2008 | WO2008089892A1 Phenothiazin derivates, method for the production thereof and use thereof as pharmaceuticals |
| 07/31/2008 | WO2008089776A1 Formulation of and method for producing an infusion rehydration solution |
| 07/31/2008 | WO2008089775A1 Method for producing a powder for amoxicillin trihydrate suspension containing sucrose |
| 07/31/2008 | WO2008089772A1 Formulation of an orodispersible coated tablet containing acetylsalicylic acid |
| 07/31/2008 | WO2008089709A2 Oxaliplatin pharmaceutical composition with alcoholic sugar-based buffer |
| 07/31/2008 | WO2008089706A1 A two-component taxane containing pharmaceutical composition |
| 07/31/2008 | WO2008089669A1 A novel combination of epimedium-derived-flavonoids-fractions for prevention of steroid-induced osteonecrosis |
| 07/31/2008 | WO2008089659A1 The use of dopamine transporters and noradrenaline transporters dual inhibitors |
| 07/31/2008 | WO2008089636A1 Derivatives of azabicyclo octane, the method of making them and the uses thereof as inhibitors of dipeptidyl peptidase iv |
| 07/31/2008 | WO2008089628A1 A nanoparticle of glucidamin for treating tumor and preparation method thereof |
| 07/31/2008 | WO2008089602A1 The tetracyclic anthraquinones possessing anti-cancer effect |
| 07/31/2008 | WO2008089594A1 Use of phthalide dipolymers for antitumor |
| 07/31/2008 | WO2008089593A1 Sustained release tamsulosin formulation and producing method |
| 07/31/2008 | WO2008089581A1 Fused aromatic ptp-1b inhibitors |
| 07/31/2008 | WO2008089580A1 Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 07/31/2008 | WO2008089557A1 Atorvastatin calcium propylene glycol solvates |
| 07/31/2008 | WO2008089549A1 Pharmaceutical compositions comprising nebivolol or a nebivolol analogue |
| 07/31/2008 | WO2008089521A1 Insulin sensitisers and methods of treatment |
| 07/31/2008 | WO2008075984A3 Tablet formulation including macrocyclic lactone and levamisole anthelmintic agents |
| 07/31/2008 | WO2008075979A3 Tablet formulation |
| 07/31/2008 | WO2008075978A3 An extract |
| 07/31/2008 | WO2008073982A3 5,6-dihydro-1h-pyridin-2-one compounds |
| 07/31/2008 | WO2008073961A9 Compounds and methods for modulating the silencing of a polynucleotide of interest |
| 07/31/2008 | WO2008073957A3 Compounds and methods for modulating the silencing of a polynucleotide of interest |
| 07/31/2008 | WO2008073403A3 Composite material for tissue repair |
| 07/31/2008 | WO2008073381A3 Synergistic effects of combinations of nornicotine and opioids for the treatment of pain |
| 07/31/2008 | WO2008071948A3 Aminoalcohol derivatives and their therapeutic use |
| 07/31/2008 | WO2008071587A3 2-(piperidin-4-yl)-4-phenoxy- or phenylamino-pyrimidine derivatives as non-nucleoside reverse transcriptase inhibitors |
| 07/31/2008 | WO2008071587A2 2-(piperidin-4-yl)-4-phenoxy- or phenylamino-pyrimidine derivatives as non-nucleoside reverse transcriptase inhibitors |
| 07/31/2008 | WO2008070529A3 A2a adenosine receptor antagonists |
| 07/31/2008 | WO2008070306A3 1,5-diphenyl-3-benzylamin0-1,5-dihydr0pyrr0lidin-2-0ne as cb1 receptor modulators |
| 07/31/2008 | WO2008070306A2 1,5-diphenyl-3-benzylamin0-1,5-dihydr0pyrr0lidin-2-0ne as cb1 receptor modulators |
| 07/31/2008 | WO2008069688A3 Methods for treating inflammatory disease by administering aldehydes and derivatives thereof |
| 07/31/2008 | WO2008068767A3 A novel crystalline form of lansoprazole |